ClinicalTrials.Veeva

Menu
R

Retinal Consultants Medical Group | Modesto, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Faricimab
Pegcetacoplan
EYE103
Aflibercept
Tarcocimab
Runcaciguat

Parent organization

This site is a part of Retinal Consultants Medical Group

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 7 total trials

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (...

Enrolling
Wet Age-related Macular Degeneration
Drug: Tarcocimab tedromer
Drug: Aflibercept

This study will demonstrate that tarcocimab 5 mg is superior to sham treatment in participants with moderately severe to severe NPDR.

Enrolling
Non-proliferative Diabetic Retinopathy
Drug: Tarcocimab
Other: Sham injection

The purpose of this Phase 2 study is comprised of two groups to evaluate the safety, tolerability, and efficacy of faricimab in patients with Non-Pro...

Active, not recruiting
Non-Proliferative Diabetic Retinopathy
Drug: Faricimab

This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.

Enrolling
Diabetic Macular Edema
Drug: Faricimab

Trial sponsors

Kodiak Sciences logo
A
Bayer logo
E
McMaster University logo
G

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems